The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gene expression profiling of paired primary breast cancers and brain metastases to identify brain metastases-specific biological changes.
 
Gaia Griguolo
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Lilly; Novartis
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
 
Maria Vittoria Dieci
Consulting or Advisory Role - Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Patents, Royalties, Other Intellectual Property - Patent pending HER2DX licensed to University of Padova
 
Susan Fineberg
Honoraria - AXDEV
Consulting or Advisory Role - AXDEV
 
Claudia Pinato
No Relationships to Disclose
 
Michele Bottosso
No Relationships to Disclose
 
Luc Bauchet
Consulting or Advisory Role - Novocure
Travel, Accommodations, Expenses - Kyowa Kirin
 
Federica Miglietta
Honoraria - Gilead Sciences; Novartis; Roche
 
Jack Jacob
No Relationships to Disclose
 
Giovanni Zarrilli
No Relationships to Disclose
 
Valerie Rigau
No Relationships to Disclose
 
Maria Cristina Guarascio
No Relationships to Disclose
 
Francesca Zanconato
No Relationships to Disclose
 
Francesca Schiavi
No Relationships to Disclose
 
Matteo Fassan
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; GlaxoSmithKline; MSD Oncology; Pierre Fabre; Roche
Research Funding - Astellas Pharma; Diaceutics; Macrophage Pharma; QED Therapeutics
 
William Jacot
Honoraria - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Eisai; Lilly O.; MSD; Novartis; Pfizer; Roche; Seagan
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Eisai; Lilly O.; MSD; Novartis; Pfizer; Roche; Seagan
Research Funding - AstraZeneca (Inst); Daiichi Sankyo Pharmaceutical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; GlaxoSmithKline; Lilly O.; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
 
Stefano Piccolo
No Relationships to Disclose
 
Amelie Darlix
No Relationships to Disclose
 
Valentina Guarneri
Consulting or Advisory Role - Eisai; Exact Sciences; Gilead Sciences; Lilly; Merck Serono; MSD; Novartis; Olema Oncology
Speakers' Bureau - Amgen; AstraZeneca; GlaxoSmithKline; Lilly; Novartis
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Roche (Inst); Synthon (Inst)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Gilead/Forty Seven